| Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924) |
|---|
| 02/21/2002 | WO2001079187A3 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/19/2002 | CA2024040C Dibenz [b,f] [1,4]oxazepin (and thiazepin)-11 (10h)-ones and-thiones and their use in the prevention or treatment of aids |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | EP0691961B1 Substituted caprolactams and derivatives thereof useful for treatment of hiv disease |
| 02/12/2002 | US6346632 Crystallization of esters of methoxyphenylglycidic acid from alcohol solvents |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | WO2001051506A3 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/05/2002 | US6344556 Thio containing monomers for polymers |
| 01/31/2002 | WO2002008211A2 Benzothiazepines and their use as antihyperlipidemics |
| 01/24/2002 | US20020010169 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004500 Drug mixture for cardiovascular disorders |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1169313A2 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/02/2002 | EP1165532A1 Antibacterial agents |
| 01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/01/2002 | CA2051830C Tricyclic heterocycles |
| 11/21/2001 | EP1155007A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 11/21/2001 | EP0659179B1 Benzo-fused lactams promote release of growth hormone |
| 11/08/2001 | US20010039272 Compounds activating pharmacological effect of retinoids |
| 11/06/2001 | US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment |
| 11/01/2001 | US20010037021 11-keto-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo(c,f)( 1,2)thiazepine is reacted with sodium borohydride in presence of chlorinated solvent and a catalyst to form alcohol, then chlorinating to form chloride, finally forming a salt |
| 10/31/2001 | CN1319593A Process for prpearing 11-amino-3-chlorine-6,11-dihydrogen-5,5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine |
| 10/25/2001 | WO2001079187A2 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 10/25/2001 | CA2406271A1 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 10/23/2001 | CA2203310C Compressed matrix for slow release of salt of tianeptine sodium following oral administration |
| 10/18/2001 | WO2001077089A1 New neurokinin antagonists for use as medicaments |
| 10/17/2001 | EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 10/17/2001 | EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 10/11/2001 | WO2001074348A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 10/11/2001 | CA2405496A1 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 10/10/2001 | EP1140190A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 10/04/2001 | EP1138677A1 Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepine and application to the synthesis of tianeptine |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/13/2001 | WO2001066533A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 09/13/2001 | CA2401055A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 09/05/2001 | CN1070484C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060808A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2400862A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/21/2001 | US6277831 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/02/2001 | WO2001055125A1 A process for the preparation of quetiapine and intermediates therefor |
| 07/25/2001 | EP1117408A1 Use of diltiazem for treating retinal pathologies |
| 07/24/2001 | CA2030162C Benzothiazepines |
| 07/19/2001 | WO2001051506A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 07/18/2001 | EP1115881A1 Process for the enzymatic kinetic resolution of 3-phenylglycidates by transesterification with aminoalcohols |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/21/2001 | WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/10/2001 | WO2001032639A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/10/2001 | CA2389439A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/08/2001 | US6228955 Catalytic epoxidation of a corresponding prochiralm, non-enolizable a/b-unsaturated ketone |
| 05/08/2001 | US6228395 Sustained-release microgranules containing Diltiazem as the active principle |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | CN1292785A Hypolipidemic benzothiazepine compounds |
| 04/19/2001 | WO2000061568A3 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/04/2001 | CN1064043C Process for preparing 1,5-benzothiazepine derivative |
| 04/03/2001 | US6211174 Osteoporosis; milk production and carcass quality in livestock; short stature; metabolic disorders |
| 03/28/2001 | EP1085863A1 Cross-reference to related applications |
| 03/13/2001 | CA2030866C Process for the preparation of an intermediate of diltiazem |
| 03/06/2001 | US6197953 Process for preparing optically active trans-3-substituted glycidic acid ester |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/22/2001 | WO1999063992A8 Novel calcium channel drugs and uses |
| 02/13/2001 | US6187936 Transesterification of mixture of trans enantiomers catalysed by enzymes in organic solvent with aminoalcohols to give mixture of trans esters, non transesterified and transesterified, having opposite configuration, separating |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 01/30/2001 | US6180785 Process for preparing diltiazem |
| 01/18/2001 | WO2001004106A1 Process for producing dibenzothiazepine derivatives |
| 01/11/2001 | DE19916108C1 Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung With sugar residues substituted 1,4-benzothiazepine-1,1-dioxide derivatives, processes for their preparation and their use |
| 01/04/2001 | WO2001000185A2 1,4-denzothiazepines to treat obesity related disorders |
| 01/04/2001 | CA2376023A1 Therapeutic agents |
| 12/26/2000 | US6166005 Heterocyclic metalloprotease inhibitors |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/20/2000 | CN1059674C Hypolipidemic benzothiazepines |
| 12/20/2000 | CN1059673C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 12/14/2000 | WO2000047568A3 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 12/13/2000 | CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv. |
| 12/12/2000 | CA2041305C Process for the resolution of 3-(4-substituted-phenyl)-glycidic acid derivatives |
| 12/06/2000 | CN1275912A Novel amide derivatives |
| 11/30/2000 | WO2000071106A2 Method of treating weight gain |
| 11/30/2000 | CA2363784A1 Method of treatment |
| 11/15/2000 | CN1273608A Process for preparing (2R, 3S)-3-(4-lower alkoxyphenyl) glycidic acid esters |
| 11/09/2000 | WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 10/25/2000 | EP1045840A1 Hypolipidemic benzothiazepine compounds |
| 10/25/2000 | CN1271340A Process for recycle of waste product of diltiazem synthesis |
| 10/19/2000 | WO2000061568A2 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 10/05/2000 | WO2000058294A1 Antibacterial agents |
| 10/03/2000 | US6127359 Bicyclic fibrinogen antagonists |
| 09/27/2000 | EP0848703B1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
| 09/19/2000 | US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 09/19/2000 | US6121256 4-(2,3-(2,5-dimethyl-2,5-hexano)dibenzo(b,f)(1,4)thiazepine-11 -yl)benzoic acid or salt |
| 09/13/2000 | CN1266430A Process for preparing optically active phenyloxirane compounds |
| 09/12/2000 | CA2030076C 2-aromatic-3-halobenzothiazepines |